Related Articles
NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation
NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma
NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
Aberrant expression of NEK2 and its clinical significance in non‑small cell lung cancer